ResMed Inc - Company Profile
Powered by 
All the sales intelligence you need on ResMed Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how ResMed Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with ResMed Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
ResMed Inc (ResMed) develops, manufactures, and distributes medical equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory conditions. It also offers software-as-a-service (SaaS) solutions to out-of-hospital health providers. ResMed's product portfolio includes airflow generators, diagnostic products, mask systems, headgear and other accessories.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
ResMed’s product development and clinical trial efforts are concentrated on enhancing existing products and exploring new digital applications. The company is committed to addressing significant unmet medical needs by identifying novel uses for its technology. Its research highlights a clinical link between untreated sleep apnea and various serious conditions including systemic hypertension, diabetes, coronary artery disease, stroke, atrial fibrillation, chronic heart failure, and increased mortality. ResMed supports clinical trials across a global network including the US, Canada, Germany, France, the UK, Switzerland, the Netherlands, Spain, Portugal, Sweden, Denmark, Iceland, Argentina, Chile, China, the Republic of Korea, Japan, Malaysia, Singapore, and Australia. These trials focus on developing new clinical applications and conducting advanced statistical analyses on millions of real-world, de-identified data points gathered through cloud-connected devices and patient engagement tools. The company’s R&D facilities are in San Diego, California; Sydney, Australia; Suzhou, China; Atlanta, Georgia; Singapore; Johor, Malaysia; and Chatsworth, California. ResMed has 1,990 individuals in its R&D division. As of June 2025, the company owned approximately 640 US patents and designs and approximately 1,450 foreign patents and designs. In FY2025, the company invested US$331.3 million in research and development, which stood at 6.4% of revenue, marking a 7.7% increase over the previous year.
Business Segments
Overview
- Provides cloud-based solutions to healthcare providers in the residential care market, including HME and home infusion providers, home health and hospice providers, skilled nursing facilities, private duty nursing organizations, senior living facilities, and life plan communities. - Aims to support healthcare providers in addressing operational and compliance complexities through cloud-based solutions, enhancing patient care and operational efficiency.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
The product portfolio includes devices, diagnostic tools, mask systems, headgear, various accessories, and dental devices. Offers cloud-connected CPAP (Continuous Positive Airway Pressure) devices, automatic positive airway pressure (APAP) devices, bilevel devices, adaptive servo-ventilation (ASV) devices, and high-flow therapy (HFT) devices, all of which deliver positive airway pressure through a patient interface such as a mask or cannula. CPAP, APAP and bilevel products include the AirSense Platform, AirMini portable CPAP and AirCurve Bilevel Platform. Ventilation products include Stellar 100 and 150, AirCurve 10 ST-A and Lumis VPAP S, ST and ST-A. Offers various mask systems including full-face masks, small nasal and nasal pillows for the treatment of sleep apnea. Major mask systems include AirFit F40, AirFit F30, AirFit P10, and AirFit N30 minimalist masks; AirFit N30i, AirFit P30i, and AirFit F30i freedom masks; AirTouch F20 and AirTouch N20 ulta soft masks; and AirFit F20 and AirFit N20 universal fit masks. Under diagnostic tools, the segment markets sleep recorders designed for diagnosing and titrating sleep apnea in sleep clinics, hospitals, and home settings. These diagnostic systems capture essential respiratory and sleep data, which can be analyzed by a sleep specialist or physician to develop a customized treatment plan for obstructive sleep apnea (OSA). Major products include NightOwl and ApneaLink Air. Under connected solutions, the segment offers a range of products that enable fewer professionals to oversee a larger number of patients, while allowing patients to monitor their health outcomes. The segment offers cloud-based platforms for patient management and engagement, facilitating remote monitoring, troubleshooting, and adjustment of device settings. Major products include AirView, Connectivity Module, U-Sleep and myAir.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer